Tada H, Mitsudomi T, Misumi T, Sugio K, et al. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT). J Clin Oncol 2021 Nov 2:JCO2101729. doi: 10.1200/JCO.21.01729.
PMID: 34726958